Battle over popular bone drug Fosamax bursts into court.
Moynihan
Ray
R
Ray.Moynihan@newcastle.edu.au
D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D007880:Legislation, Drug; D009519:New York City; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000188:drug therapy; D012307:Risk Factors; D013577:Syndrome
D050071:Bone Density Conservation Agents; D019386:Alendronate